Estimates Revisions Santen Pharmaceutical Co., Ltd. Börse Stuttgart
Stocks
SZD
JP3336000009
Pharmaceuticals
|
Real-time Estimate
Tradegate
11:55:33 07/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 9.425 EUR | +1.34% |
|
-0.53% | +6.90% |
| 10-01 | SpyGlass Pharma Acquires Advanced Vision Science for $13 Million | MT |
| 10-01 | SpyGlass Pharma, Inc. acquired Advanced Vision Science, Inc. from Santen Pharmaceutical Co., Ltd. for $13 million. | CI |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Data source:
Santen Pharmaceutical Co., Ltd.(4536)
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Data source:
Santen Pharmaceutical Co., Ltd.(4536)
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
Data source:
Santen Pharmaceutical Co., Ltd.(4536)
EBIT
Dividend / Share (DPS)
Data source:
Santen Pharmaceutical Co., Ltd.(4536)
Cash or Net Debt
- Stock Market
- Stocks
- 4536 Stock
- SZD Stock
- Consensus Santen Pharmaceutical Co., Ltd.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
